OFIX

OFIX R&D to Revenue

6.95%Fiscal year

Period ending:

OFIX FY R&D/Revenue%
OFIX FY R&D/Revenue16.86%-1.81%
1991-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

OFIX r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 35 observations from Dec 31, 1991 to Dec 31, 2025.

Orthofix Medical Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
6.9453%
9.2112%
10.7456%
10.6498%
10.6832%
9.6064%
7.5305%
7.3322%
6.8461%
7.0288%
6.6557%
6.2131%
6.6831%
6.1812%
4.3434%
5.3777%
5.7658%
5.9352%
4.9396%
15.0515%
3.6121%
4.0019%
3.99%
4.2282%
4.3022%
5.2261%
5.2793%
5.6676%
5.3333%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All OFIX financial metrics · OFIX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.